Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2010
08/10/2010US7770511 Method and device for preparing liquid
08/10/2010CA2361238C Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/10/2010CA2243235C Immunotherapy using cytotoxic t lymphocytes (ctl)
08/10/2010CA2180032C Gene expression control
08/05/2010WO2010088547A1 Assays for detecting pegylated blood coagulation factors
08/05/2010WO2010088544A1 Methods to treat cancer
08/05/2010WO2010087521A1 Combined preparation for treating joint diseases
08/05/2010WO2010087335A1 T CELL ANTIGEN RECEPTOR GENE, VECTOR FOR EXPRESSION OF RECEPTOR α-CHAIN AND β-CHAIN, AND CYTOTOXIC T CELL
08/05/2010WO2010087283A1 Method for controlling propagation of umbilical cord blood hematopoietic stem cells and use thereof
08/05/2010WO2010087131A1 Hiv replication inhibitor, and use thereof
08/05/2010WO2010086838A2 Non-ad5 adenoviral vectors and methods and uses related thereto
08/05/2010WO2010086679A1 Myeloid-derived suppressor cells generated in vitro
08/05/2010WO2010086322A1 Composition comprising chicoric acid and/or derivatives thereof
08/05/2010WO2010085876A1 Thylakoids and their functional derivatives, and their uses
08/05/2010WO2010085842A1 Lung epithelial progenitor cells, uses thereof and processes for production
08/05/2010WO2010062905A9 Lateral ventricle cell compositions and use for treating neural degenerative diseases
08/05/2010WO2010056765A3 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
08/05/2010WO2009052617A9 Treatment regime for proliferative disorders
08/05/2010US20100197015 Human liver progenitors
08/05/2010US20100196998 System and method for electroporating a sample
08/05/2010US20100196916 Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
08/05/2010US20100196910 Methods of generating human cardiac cells and tissues and uses thereof
08/05/2010US20100196870 Sterilized xenograft tissue
08/05/2010US20100196524 Novel peptides and methods for producing them
08/05/2010US20100196517 Topical delivery of a nitric oxide donor to improve body and skin appearance
08/05/2010US20100196499 Xenograft Bone Matrix for Orthopedic Applications
08/05/2010US20100196498 Emulsion hydro therapy or milk therapy for treatment of psoriasis
08/05/2010US20100196497 Method of Treating Tissue Using Platelet-Rich Plasma in Combination with Low-Level Laser Therapy
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196493 Method for producing stable powder compositions
08/05/2010US20100196489 Bone growth particles and osteoinductive composition thereof
08/05/2010US20100196480 Graft materials containing bioactive extracellular matrices and cells
08/05/2010US20100196478 Protein matrix materials, devices and methods of making and using thereof
08/05/2010US20100196461 Resuscitation fluid
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196444 Devices with cells cultured on flexible supports
08/05/2010US20100196442 Methods for treating open wounds
08/05/2010US20100196441 Uses of immunologically modified scaffold for tissue prevascularization cell transplantation
08/05/2010US20100196439 Angiogenesis Mechanism and Method, and Implantable Device
08/05/2010US20100196438 Methods including medical devices having a surface including a biologically active agent therein
08/05/2010US20100196433 Prevascularized devices and related methods
08/05/2010US20100196432 Biopolymer structures
08/05/2010US20100196423 soluble neutral active Hyaluronidase Glycoproteins (sHASEGPs); use treating glycosaminoglycan associated pathologies such as tumors or eye disorders; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes
08/05/2010US20100196406 Agents for the treatment of inflammatory diseases and methods of using same
08/05/2010US20100196394 Anti-cancer vaccine composition
08/05/2010US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo
08/05/2010US20100196349 Reeler domain containing protein
08/05/2010US20100196347 Bone grafts with reduced protease activity and methods of selection and use
08/05/2010US20100196341 Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
08/05/2010US20100196340 Lactid acid bacteria as priobiotic strains and compositions containing same
08/05/2010US20100196338 Compositions and methods for treating cardiovascular disease
08/05/2010US20100196337 Methods and compositions for stem cell self-renewal
08/05/2010US20100196335 Methods and Compositions for Regulated Expressions of Nucleic Acid at Post-Transcriptional Level
08/05/2010US20100196334 Cell Suspension Preparation Technique and Device
08/05/2010US20100196333 Device and Process for Producing Fiber Products and Fiber Products Produced Thereby
08/05/2010US20100196332 Generation of brachial, thoracic and lumbar spinal motor neurons from embryonic stem cells in the absence of all-trans retinoic acid supplement
08/05/2010US20100196331 Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
08/05/2010US20100196330 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
08/05/2010US20100196329 Composition for treating ischemic limb disease comprising stem cells derived from adipose tissue
08/05/2010US20100196328 ISCHEMIA-INDUCED NEOVASCULARIZATION IS ENHANCED BY hCNS-SC TRANSPLANTATION
08/05/2010US20100196327 Methods for diagnosing biological samples containing stem cells
08/05/2010US20100196326 Method and system for biasing cellular development
08/05/2010US20100196325 Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods
08/05/2010US20100196324 Multifunctional cytokines
08/05/2010US20100196323 Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof
08/05/2010US20100196322 Polymer for tissue engineering applications and drug delivery
08/05/2010US20100196314 Modified Two-Component Gelation Systems, Methods of Use and Methods of Manufacture
08/05/2010US20100196313 Modified Two-Component Gelation Systems, Methods of Use and Methods of Manufacture
08/05/2010US20100196311 METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES
08/05/2010US20100196297 Urine as a source of alternative cellular energy pigments (ACE-pigments) in the Assesment and therapy of diseases
08/05/2010DE102009013552A1 Emulsionen und Verfahren zu ihrer Herstellung Emulsions and methods for their preparation
08/05/2010CA2750770A1 Non-ad5 adenoviral vectors and methods and uses related thereto
08/05/2010CA2750685A1 Composition comprising chicoric acid and/or derivatives thereof
08/05/2010CA2749204A1 Methods to treat cancer
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213740A1 Human telomerase catalytic subunit
08/04/2010EP2213730A1 Primary cultured adipocytes for gene therapy
08/04/2010EP2213309A1 Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent
08/04/2010EP2213300A1 Composition and method for treating cancer using herpes virus
08/04/2010EP2212423A2 Poxviral oncolytic vectors
08/04/2010EP2211890A1 Methods of treating urogenital-neurological disorders using modified clostridial toxins
08/04/2010EP2211880A1 Treatment regime for proliferative disorders
08/04/2010EP2211879A1 Probiotic compositions and methods for inducing and supporting weight loss
08/04/2010EP2211878A2 Calcium-mediated effects of coral and methods of use thereof
08/04/2010EP2211877A1 Scar tissue treatment system
08/04/2010EP2211875A1 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
08/04/2010EP2211857A1 Use of quaternary pyridinium salts for radioprotection
08/04/2010EP1032675B1 Attaching substances to micro-organisms
08/04/2010CN1899441B Chinese medicine paste for burn and its preparing method
08/04/2010CN101796187A Double-stranded RNA originating in lactic acid bacterium
08/04/2010CN101796074A Anti-notch1 NRR antibodies and methods using same
08/04/2010CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody
08/04/2010CN101795697A Gastropod biological fluid, method of making and refining and use
08/04/2010CN101795693A Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol
08/04/2010CN101792776A Recombinant adenovirus vector for efficiently inducing pluripotent stem cell (PS cell), method for inducing PS cell by using recombinant adenovirus vector and usage of recombinant adenovirus vector
08/04/2010CN101792737A Culture method, application and combined preparation of hypoxia mesenchymal stem cell
08/04/2010CN101792732A Techniques for growth and differentiation of human pluripotent stem cells
08/04/2010CN101791391A Traditional Chinese medicine composition for treatment of cardiovascular infarction syndrome and preparation method thereof
08/04/2010CN101791390A Traditional Chinese medicine compound composition for treating sequelae of cerebral infarction and cerebral hemorrhage and processing method thereof
08/04/2010CN101791388A Traditional Chinese medicine preparation for treating peptic ulcer
1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 1259